Impiricus, a startup connecting physicians to pharmaceutical companies, will pursue a private equity deal in Q1 of next year, president Sandy Donaldson tells Axios Pro exclusively.
Why it matters: Increased federal scrutiny on DTC pharma ads is shifting money toward channels that engage doctors directly.
